Literature DB >> 6690266

Management of patients with polyps containing malignancy removed by colonoscopic polypectomy.

J C Langer, Z Cohen, B R Taylor, S Stafford, K N Jeejeebhoy, J B Cullen.   

Abstract

The management of malignant colonic polyps removed colonoscopically has been a controversial subject. A continuing series is reported of 36 patients with 37 malignant polyps removed by colonoscopic polypectomy (CP) between 1976 and 1982. Fourteen polyps contained carcinoma in situ (CIS); 13 were treated by CP alone; one was treated by CP and colectomy. Nineteen polyps contained invasive carcinoma; 13 were treated by CP alone; six were treated by CP and colectomy. Four patients had sessile polyps resected piecemeal, in which accurate staging was impossible. Two were treated with CP alone, and two had CP plus colectomy. All patients were followed with yearly colonoscopy and/or barium enema. Follow-up has been six to 84 months (mean 36 months). Twenty-seven patients whose polyps were treated by CP alone have had no evidence of recurrent tumor at the polypectomy site. Of the nine patients undergoing colectomy, six had residual tumor at the polypectomy resection site. No patients had involved lymph nodes. Our current approach to this problem is based on the degree of invasion and the status of the resection margins. Polyps containing CIS can safely be treated with CP alone. Polyps with invasive carcinoma and clear resection margins should be treated with CP and either colectomy or frequent repeat colonoscopy. This decision is a clinical one and must involve input from both the clinician and the pathologist. Those polyps whose resection margins are involved or where piecemeal excision precludes accurate pathologic assessment should undergo colectomy.

Entities:  

Mesh:

Year:  1984        PMID: 6690266     DOI: 10.1007/bf02554062

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  10 in total

1.  Large bowel adenomas containing carcinoma--a diagnostic and therapeutic approach.

Authors:  F P Rossini; A Ferrari; S Coverlizza; M Spandre; M Risio; C Gemme; M Cavallero
Journal:  Int J Colorectal Dis       Date:  1988-03       Impact factor: 2.571

2.  Colonoscopic polypectomy and management of malignant colorectal polyps--a review in an Irish population.

Authors:  F E Murray; M G Lombard; R Fitzgerald; P Dervan; J R Lennon; J Crowe
Journal:  Ir J Med Sci       Date:  1988-01       Impact factor: 1.568

3.  Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis.

Authors:  S Tanaka; K Haruma; C R Teixeira; S Tatsuta; N Ohtsu; Y Hiraga; M Yoshihara; K Sumii; G Kajiyama; F Shimamoto
Journal:  J Gastroenterol       Date:  1995-12       Impact factor: 7.527

4.  Risk factor assessment of endoscopically removed malignant colorectal polyps.

Authors:  P Netzer; C Forster; R Biral; C Ruchti; J Neuweiler; E Stauffer; R Schönegg; C Maurer; J Hüsler; F Halter; A Schmassmann
Journal:  Gut       Date:  1998-11       Impact factor: 23.059

5.  Patient management after endoscopic removal of the cancerous colon adenoma.

Authors:  W O Richards; W A Webb; S J Morris; R C Davis; L McDaniel; L Jones; S Littauer
Journal:  Ann Surg       Date:  1987-06       Impact factor: 12.969

6.  Long-term prognosis of well-differentiated adenocarcinoma in endoscopically removed colorectal adenomas.

Authors:  K N Cunningham; L R Mills; B M Schuman; D H Mwakyusa
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

7.  Experience with 1000 colonoscopic polypectomies.

Authors:  W A Webb; L McDaniel; L Jones
Journal:  Ann Surg       Date:  1985-05       Impact factor: 12.969

8.  Treatment of carcinoma in adenomas.

Authors:  T Muto; T Sawada; K Sugihara
Journal:  World J Surg       Date:  1991 Jan-Feb       Impact factor: 3.352

9.  The use of endoscopic biopsy in evaluation of polypoid lesions of the colon.

Authors:  K W Barwick
Journal:  Yale J Biol Med       Date:  1986 Jan-Feb

10.  Screening and the costs of treating colorectal cancer.

Authors:  D K Whynes; A R Walker; J O Chamberlain; J D Hardcastle
Journal:  Br J Cancer       Date:  1993-11       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.